Medable is at the forefront of transforming clinical research with its unified Evidence Generation Platform, designed to accelerate the delivery of new therapies. Specializing in decentralized clinical trials (DCTs), the company empowers sponsors, CROs, and research sites to conduct patient-centric studies that improve access, diversity, and engagement. By integrating digital solutions like eConsent, eCOA, and TeleVisit, Medable's flexible platform removes traditional barriers, enabling a more seamless experience for both patients and site staff. This modern approach streamlines data collection and enhances evidence quality, ultimately shortening development timelines. Through its commitment to digital innovation, Medable is dedicated to making participation in clinical trials more convenient and bringing effective treatments to patients faster.